Winston Patrick Kuo
Winston Patrick Kuo (winston.kuo@ cloudhealth99.com) is the chief technology officer and head of business development with CloudHealth Genomics, Ltd., Shanghai, China. He was formerly president of Predicine Holdings Ltd., an international precision-medicine organization committed to developing innovative diagnostics, therapeutics, and big data in cancer and other serious diseases; he was chief operating officer with IES Diagnostics. Prior to industry, Dr. Kuo was an assistant professor in the Department of Developmental Biology at the Harvard School of Dental Medicine, and he was director and founder of the Harvard Clinical and Translational Science–Laboratory for Innovative Translational Technologies at the Harvard Medical School to provide the university’s biomedical research community with early access to disruptive and enabling leading-edge translational technologies.
IEEE PULSE, Feature January/February 2017Cancer Liquid Biopsy
The management of cancer relies on a combination of imaging and tissue biopsy for diagnosis, monitoring, and molecular classification-based patient stratification to ensure appropriate treatment. Conventional tissue biopsy harvests tumor samples with invasive procedures, which are often difficult for patients... Read more
Posted on 15 FEB 2017